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SUMMARY
This review will highlight recent progress and current in-
formation supporting an active role for intestinal lymphatic
vessels in transport and distribution of dietary lipids.
Modulation of gut lymphatics might represent a novel
therapeutic strategy to prevent diet-induced obesity and the
metabolic syndrome.
The lymphatic system of the gut plays important roles in the
transport of dietary lipids, as well as in immunosurveillance
and removal of interstitial ﬂuid. Historically, despite its
crucial functions in intestinal homeostasis, the lymphatic
system has been poorly studied. In the last 2 decades,
identiﬁcation of speciﬁc molecular mediators of lymphatic
endothelial cells (LECs) growth together with novel genetic
approaches and intravital imaging techniques, have
advanced our understanding of the mechanisms regulating
intestinal lymphatic physiology in health and disease. As its
metabolic implications are gaining recognition, intestinal
lymphatic biology is currently experiencing a surge in inter-
est. This review describes current knowledge related to
molecular control of intestinal lymphatic vessel structure
and function.Wediscuss regulationof chylomicronentry into
lymphatic vessels by vascular endothelial growth factors
(VEGFs), hormones, transcription factors and the speciﬁc
signaling pathways involved. The information covered sup-
ports the emerging role of intestinal lymphatics in etiology of
the metabolic syndrome and their potential as a therapeutic
target. (Cell Mol Gastroenterol Hepatol 2019;7:503–513;
https://doi.org/10.1016/j.jcmgh.2018.12.002)
Keywords: Lacteals; Lipid; VEGF Signaling; Endothelium;
Obesity.
The lymphatic vasculature plays crucial roles in tis-sue ﬂuid homeostasis, immune surveillance, and
transport of dietary fat from the intestine to the blood-
stream.1–3 The latter function was already noted in 1662 by
the Italian physician Gaspare Aselli when he described the
lacteal vessels, or chyliferous vessels, in the intestine of a
well-fed dog.4 However, relatively modest attention has
been given to dietary lipid transport by the lymphatic sys-
tem because it was generally considered to involve passive
unregulated drainage. In the last 2 decades, identiﬁcation of
speciﬁc markers for lymphatic endothelial cells (LECs)
allowed the generation of lymphatic-reporter mouse
models, that combined with state-of-the-art imaging of
lymphatic structure have enhanced our understanding of
gut lymphatic physiology in health and disease. Currently,
the ﬁeld of gut lymphatics is experiencing a surge in interest
as the metabolic implications of intestinal lymphatics and
their potential as a target in the management of obesity and
its complications are becoming more appreciated.
Numerous studies have now shown that lipid transport by
lacteals is a tightly regulated active process, and that
impairment of this regulation could lead to systemic meta-
bolic consequences. The molecular mechanisms regulating
lipid uptake and transport by lacteals will be discussed with
a focus on their impact in control of energy metabolism.
Functional Organization of Intestinal
Lymphatics
Unlike the closed loop formed by the blood-vascular
network, the lymphatic system is a unidirectional trans-
port system designed to return ﬂuid to the blood circulation.
The lymphatic network consists of blind-ended capillaries
located in most tissues that funnel into progressively fewer
and larger precollecting and collecting vessels. Lymph from
the gastro-intestinal and lumbar region drains into the
cisterna chyli at the posterior end of the thoracic duct and
enters the circulation at the level of the subclavian vein.5,6
In the intestine, lymphatic capillaries, or lacteals, are
located exclusively in intestinal villi, whereas collecting
lymphatic vessels are present in the mesentery.7 The term
gut lymphatics used throughout this review refers to both
lacteals in the intestinal villi and lymphatic vessels in
the submucosa. The structural organization of intestinal
stroma has been elegantly described by Bernier-Latmani
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et al,8,9 who also provide detailed protocols for generating
high-resolution 3-dimensonal images of gut cell types
including blood and lymphatic vessel cells, smooth muscle
cells, ﬁbroblasts, and immune cells.
Lacteal length normally reaches 60%–70% of villus length
and this proportion does not differ along the different intesti-
nal segments.8 Lacteals are surrounded by a highly organized
cage-like structure of arterial and venous blood capillaries and
by a treelike set of smooth muscle ﬁbers (Figure 1) usually
identiﬁed by staining for a–smooth muscle actin and desmin.8
Extracellular matrix proteins in the intestinal villus interact
with LECmembrane proteins, notably the integrins, to regulate
lymphangiogenesis and aspects of lacteal function.10 For
example, integrin b1, expressed in intestinal blood and LEC
vessels,8 is required for the proliferative response of LECs to
ﬂuid accumulation and cell stretching.11 Integrin a9, prefer-
entially expressed on LECs, is important for providing ﬁbro-
nectin matrix support during lymphatic valve
morphogenesis.12 Additional active matrix components
located within the intestinal stroma include tenascin C, found
in the villus but almost undetectable in the submucosa, which
functions in tissue stretching, injury, and inﬂammation,13 and
periostin, important for tissue remodeling in response to
injury, present mostly in pericryptal ﬁbroblasts.8 Of interest,
the matrix protein Mfge8 (milk fat globule epidermal growth
factor–like 8), a ligand for integrins avb3, avb5, and a8b1 has
been reported to inﬂuence intestinal lipid absorption.14,15
However, additional studies are needed to elucidate whether
Mfge8 might inﬂuence chylomicron (CM) transfer to lacteals.
Adult lacteals undergo continuous remodeling; presence
of ﬁne cytoplasmic, actin-rich cellular extension, or ﬁlopodia,
is observed in the majority of lacteal tips, indicating active
regeneration in contrast to what is observed in other
lymphatic beds that are more quiescent. Lymphatic ECs use
glycolysis and fatty acid b-oxidation (FAO) for energy pro-
duction during proliferation and migration.16,17 FAO gener-
ates acetyl-coenzyme A used by the histone acetyltransferase
p300 for histone acetylation of key genes involved in lym-
phangiogenesis. In vitro, LECs as compared with microvas-
cular ECs have higher expression of fatty acid binding protein
FABP4 and FABP5, fatty acid transport proteins FATP3 and
FATP4, and long-chain fatty acid translocase CD36, support-
ing the importance of FAO in LECs.17
Important components of lacteal structure and function
are cell-cell junctions. LECs are connected by functionally
specialized junctions containing both adherens and tight
junction proteins, such as vascular endothelial cadherin and
claudin-5. LECs in initial lymphatics are interconnected by
discontinuous button-like junctions, whereas downstream
the collecting lymphatics display continuous zipper-like
junction located at the cell borders with no openings.18,19
The transition of button to zipper junction pattern
(Figure 2) reﬂects functional differences between regions
specialized for ﬂuid uptake (button) or for lymph transport
(zipper). The ﬂap-like openings between adjacent “buttons”
allow access of interstitial ﬂuid and immune cells into the
lymphatic capillary lumen. The collecting vessels are less
permeable because of the continuous cell-cell junctions,
which avoids lymph leakage during transport from capil-
laries to lymph nodes.18 Lacteals display a mix of continuous
and discontinuous junctions, demonstrating features of both
sprouting and quiescent lymphatic capillaries.8 Lacteal
junctions have been recently shown to regulate CM entry
into the lacteals,20 as discussed subsequently.
Molecular Regulation of Intestinal
Lymphatics
Recent studies have shown that defective lacteal lym-
phangiogenesis impairs absorption of dietary lipid. In this
section, we review the molecular regulation of lym-
phangiogenesis and discuss rodent models of dysfunctional
gut lymphatics and mesenteric lymphatic vessels, due to
genetic deletion of prospero homeobox protein 1 (Prox1),21
vascular endothelial growth factor (VEGF)-C,22 notch ligand
delta-like ligand 4 (DLL4),8 and adrenomedullin,23 which
causes impaired absorption of lipids.
During embryonic development, lymphangiogenesis is
primarily guided by VEGF-C via binding of its tyrosine
Figure 1. Functional structure of lacteals. Schematic
showing lacteal structure and drainage of dietary lipids in
the intestine. Lacteals are surrounded by villus smooth
muscle ﬁbers (in red). The majority of lacteal tips present
ﬁlopodia, which are cytoplasmic, actin-rich cellular exten-
sions indicating active regeneration.8 Lacteal LECs have a
mix of button- and zipper-like junctions and more ﬁlopodia
are found on zipper junction–enriched lacteals. Dietary lipids
are absorbed on the apical side of enterocytes. Once inside
the lacteals, CMs are transported via the lymph through
mesenteric lymph nodes and collecting lymphatic vessels,
ultimately reaching the thoracic duct, which drains into the
venous circulation at the level of the left subclavian vein.
504 Cifarelli and Eichmann Cellular and Molecular Gastroenterology and Hepatology Vol. 7, No. 3
Downloaded for Anonymous User (n/a) at Washington University School of Medicine from ClinicalKey.com by Elsevier on May 22, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
kinase VEGF receptor 3 (VEGFR-3) which is highly
expressed in LECs. The fully processed form of VEGF-C can
also bind to VEGFR-2.24,25 In the absence of VEGF-C, the
development of lymphatic vessels is arrested during their
initial spouting from embryonic veins as VEGF-D, the second
VEGFR-3 ligand, does not compensate for absence of VEGF-
C.25 Lacteal vessels grow into the intestinal villi around
embryonic day E17.5 to facilitate postnatal lipid absorp-
tion.26 These lymphatic plexuses and capillaries in the
intestinal tube form through an active branching process
associated with activation of VEGFR-3 by VEGF-C, and
involvement of lymphatic vessel endothelial hyaluronan
receptor 1–positive macrophages.26 Interstitial ﬂow is also
critical for guiding lymphangiogenesis through the genera-
tion of a VEGF-C gradient that dictates direction of vessel
growth.27,28
VEGF-C is synthetized as a pre-pro-peptide (58 kDa) that
undergoes a ﬁrst cleavage in the C-terminal part by furin,
resulting in pro–VEGF-C (29/31 kDa), and subsequently in
the N-terminal part, yielding its active form (21/23 kDa).29
Pro-VEGF-C is secreted and can bind VEGFR-3 in LECs but
fails to activate phosphorylation of VEGFR-3 or that of
downstream signaling proteins; extracellular signal-related
kinases (ERK1/2), AKT, or endothelial nitric oxide (NO)
synthase.30 Mature VEGF-C can also activate VEGFR-2.29
Upon binding with VEGF-C, VEGFR-3 forms homodimers
and undergoes intrinsic autophosphorylation on at least 5
cytoplasmic tyrosines (Y1230, Y1231, Y1265, Y1337, and
Y1363).31 VEGFR-3 activation leads to protein kinase C-
dependent activation of ERK1/2, implicated in cell prolifer-
ation.32,33 VEGF-C can also induce formation of heterodimers
between VEGFR-3 and VEGFR-2 through a different phos-
phorylation pattern.31,34 The VEGFRs signaling cascades are
also regulated by co-receptors such as neuropilin 1 and 2
(NRP1 and NRP2), non–tyrosine kinase transmembrane
proteins that bind VEGFs.35 Recent studies in LECs show that
VEGF-C activates AKT signaling via formation of VEGFR-2/
VEGFR-3/NRP1 complex while ERK is activated by VEGFR-
3 homodimers without contribution of NRP1 or NRP2.36,37
These studies were done in cultured LECs in vitro, but
NRP1 is not detected in intestinal LECs in vivo. Comprehen-
sive recent review articles are available detailing VEGF
signaling pathways in lymphangiogenesis.37–39
Prox1
Homeobox gene Prox1 is a transcription factor critical for
lymphatic lineage commitment and the formation of the
Figure 2. Regulation of chylomicron uptake by VEGF-A. Schematic model of cell-cell junctions in intestinal blood ECs
and LECs regulating chylomicron absorption. (A) VEGF-A binding to NRP1/Fms-related tyrosine kinase 1 (FLT1) on blood
ECs limits VEGF-A bioavailability for VEGFR-2, resulting in continuous cell junctions in blood ECs and in discontinuous ones
on LECs. The discontinuous button-like LEC junctions allow lacteal to take up CMs. (B) Inducible genetic deletion of Nrp1 and
Flt1 increase bioavailability of VEGF-A and subsequent signaling through VEGFR-2. High level of VEGF-A promotes transition
of button-to-zipper junctions in the lacteals, which inhibits chylomicron entry into the lymphatic capillaries causing lipid
malabsorption and reduced weight gain during high-fat feeding. These data support the hypothesis that NRP1 and FLT1
function together as a double decoy receptor system in intestinal blood ECs to limit VEGF-A signaling.20
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lymphatic vasculature.40,41 Homozygous genetic deletion of
Prox1 in mice results in absence of lymphatic vessels, severe
edema and death at around embryonic day 14.5 (E14.5).40
Prox1þ/– pups often die right after birth due to presence
of pulmonary edema or lymphangienctasia,21 similar to the
phenotype observed in mice with a deletion in the gene
Ccbe1, Collagen And Calcium Binding EGF Domains 1,42 a
regulator of the cleavage of pro–VEGF-C into its active
form.30 The surviving Prox1þ/– pups that reach adulthood
develop spontaneous obesity.21 Heterozygous loss of Prox1
leads to defective lymphatic vascular integrity and subtle
leakage of lymph in the visceral area. The accumulated
lymph induces de novo differentiation of fat cell precursors,
fat cell hypertrophy, and eventually adipocyte proliferation,
and with age, Prox1þ/– mice became progressively obese.43
Prox1þ/– mice display dilated and dysfunctional submucosal
and lymphatic vessels in the mesentery, increased mesen-
teric fat deposition and accumulation of inﬂammatory
cells.21 These ﬁndings represent the ﬁrst deﬁnitive studies
highlighting importance of Prox1-mediated loss of gut
lymphatic vessel integrity in the etiology of obesity.
VEGF-C and VEGFR-3/VEGFR-2
In the intestine, VEGF-C is secreted by smooth muscle
cells located in the inner circular muscle layer of the in-
testinal wall, in arterial smooth muscle, and in a subset of
the SMC ﬁbers in the villus within the intestinal wall22 and
surrounding the lacteals.44 Additional cell types in the gut
are equipped to produce VEGF-C, such as macrophages45
and ﬁbroblasts,46 but their contribution to VEGF-C secre-
tion in the intestine is unclear. Postnatal inducible global
deletion of Vegfc in mice associates with defective lipid
absorption and increased excretion of cholesterol and free
fatty acid in feces. Despite no difference in food intake,
Vegfc–/– mice are protected from diet-induced obesity and
insulin resistance, compared with littermate control mice,
although the link between defective lacteal lymphangio-
genesis and improved glucose sensitivity was not investi-
gated.22 Vegfc deletion causes lacteal regression without
affecting maintenance of other lymphatic beds, although the
VEGF-C/VEGFR-3 pathway also plays critical functions also
in the heart47 and brain.48 The same study found that,
similar to Vegfc deletion, inducible global deletion of Vegfr3
postnatally affected lacteal maintenance and function. Of
interest, lymphatic vessel density in the intestinal wall was
not altered, suggesting that VEGF-C can signal via VEGFR-2
to stabilize the lymphatic plexus.22 The role of Vegfr2 in
intestinal lymphatic function has not been investigated yet.
Recently, Shew et al49 showed that inactivation of VEGFR-
3 tyrosine kinase motif in mice50 leads to retention of tri-
glycerides (TGs) in the enterocytes of the small intestine,
with decreased postprandial levels of TGs in the plasma and
increased excretion of lipids into the stools. The study further
showed that after a fat bolus levels of NO, which is required
for CM mobilization into the bloodstream,51 are signiﬁcantly
reduced in intestines of mice with the mutant VEGFR-3. This
observation suggested a critical role for VEGFR-3 signaling in
the generation of NO during lipid absorption.49
Delta-Like Ligand 4
Lacteal regeneration was recently shown to be regulated
by DLL4, a Notch ligand. Activation of VEGFR-3/VEGFR-2
signaling cascade by VEGF-C was required to promote
DLL4 expression in the lacteals. DLL4 was highly expressed
in tip cells of sprouting lacteals and had a lower expression
in stalk cells. Inducible deletion of Dll4 in LECs affected
lacteal LEC tip cell phenotypes and survival. Dll4–/– lacteals
were shorter than those of wildtype mice because of
decreased ﬁlopodia, impaired cell survival and migration.
Deletion of lymphatic Dll4 promotes a transition from mixed
adherens junctions to mostly continuous junctions, causing
inefﬁcient CM uptake and transport.8
Adrenomedullin
Adrenomedullin is a small (52 amino acid) peptide
highly expressed in LECs and regulated by Prox1 that is
required for normal development of the lymphatic system.52
Adrenomedullin binds the G protein–coupled calcitonin
gene-related peptide type 1 receptor (CALCRL) and its
signaling directly promotes endothelial cell growth and
survival through activation of MAPK/ERK pathways.53
Adrenomedullin regulates lymphatic permeability via junc-
tions ZO-1 and vascular endothelial cadherin at the cell
membrane.54 Inducible deletion of Calcrl in LECs results in
dilated intestinal lymphatics and protein-losing enteropathy
that are characteristic of clinical intestinal lym-
phangiectasia.23 Calcrl-deﬁcient mice have smaller body
weight compared with littermate control mice, and impaired
lipid absorption possibly due to lacteal defects.
Role of Gut Lymphatics in Lipid
Absorption
Digestion and absorption of dietary lipid in the gastro-
intestinal tract involves multiple steps. First, hydrolysis of
neutral lipids in the gut lumen generates fatty acids and
monoglycerides, which transfer through the apical mem-
brane of mucosal enterocytes, where endoplasmic reticulum
enzymes re-esterify them into TGs. Second, the TGs together
with cholesterol, cholesteryl esters, phospholipids, and
ApoB, are assembled into CMs that are released from the
enterocyte’s basolateral membrane55 and enter the intesti-
nal lymphatic lacteals.56–58
The molecular mechanisms regulating CM uptake by
lacteals are emerging and support the concept that CM entry
into lacteals is an active process, as opposed to the notion of
passive draining from the interstitium of particulates too
large to enter blood capillaries.59 CM uptake by lacteals is
regulated by the transcription factor pleomorphic adenoma
gene-like 2 (PlagL2). PlagL2 null mice have functional
enterocytes that secrete CMs but the CMs fail to enter the
lacteals60; however, the mechanisms remain unknown.
VEGF-A Regulates CM Uptake by Lacteals via
Modulation of Cell-Cell Junctions
A recent study showed that VEGF-A signaling
regulates CM uptake through modulation of lacteal
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junctions.20 VEGF-A is the prototype member of the VEGFs
family, and has key roles in hematopoiesis, vasculogenesis,
angiogenesis, and vascular permeability, mainly mediated
through VEGFR-2 signaling.61 VEGF-A binds with higher af-
ﬁnity to VEGFR-1, although this interaction results in limited
downstream signaling. VEGFR-1 (also known as Flt1) is
considered to be a decoy receptor that limits VEGF-A avail-
ability for VEGFR-2 and therefore activation and signaling of
the VEGF-A/VEGFR-2 axis (decoy-or-sink hypothesis).62,63
VEGF-A also binds to semaphorin receptor NRP1,64 a sin-
gle spanning non–tyrosine kinase transmembrane protein
that functions as a VEGFR-2 co-receptor. NRP1 regulates
VEGFA-mediated endothelial permeability via VEGFR-2
phosphorylation and activation of downstream
signaling.65,66 Zhang et al20 showed that inducible genetic
deletion of Nrp1 and Vegfr1 (also known as Flt1) increase
VEGF-A bioavailability and signaling through VEGFR-2. High
level of VEGF-A induces button-to-zipper junction trans-
formation in the lacteals, which inhibits CM entry into the
lymphatic capillaries causing lipid malabsorption and
reduced weight gain during high-fat feeding (Figure 2A and
B). These observations suggested that NRP1 and Fms-related
tyrosine kinase 1 function together as a double decoy re-
ceptor system in intestinal blood endothelial cells to limit
VEGF-A signaling in lymphatic vessels. Interestingly, the
Vegfa gene is highly expressed in intestinal villi as compared
with Vegfc and Vegfb20; however, expression of its decoy
receptor Flt1 increases at birth, concomitant with expression
of the CM processing proteins Mtp and ApoB, which induces
Flt1.67 Thus, postnatal generation of CMs leads to increased
expression of Fms-related tyrosine kinase 1 in intestinal
blood ECs, which together with NRP1 prevents excessive
VEGF-A signaling at the level of the lymphatics, allowing
lacteal junction maturation and CM absorption.20 The study
demonstrates that high VEGF-A signaling has opposite
effects on blood and lymphatic vessels: it increases leakage
of blood capillaries by opening normally closed cell-cell
junctions, and reduces permeability of lacteals by closing
junctions via transformation of buttons into zippers
(Figure 2A and B). In addition, VEGFR-2 activation on LECs
inhibits vascular endothelial cadherin cytoskeletal
anchoring, which helps maintain lacteal button junctions as
open. VEGF-A gain of function for a short period is sufﬁcient
to induce a switch in junction morphology and therefore
lipid uptake. The opposite effects of VEGF-A on lymphatic
and blood vasculature is possibly explained though inhibi-
tion of Rho-associated protein kinases, which promote
zippering of endothelial cell junctions and suppress CM
uptake into lacteals. Rho-associated protein kinase inhibitors
have been previously reported to reduce leakage in blood
vessels.68 Overall, the ﬁndings support importance of Nrp1
and VEGFR-1 in limiting VEGF-A activity during CM gener-
ation for promoting lymphatic transport of the absorbed
lipid. Of interest, Khalifeh-Soltani et al15 showed that ligation
of a8b1 by the milk protein Mfge8 reduces antral smooth
muscle contractile force by preventing RhoA activation
through a phosphatase and tensin homolog–dependent
mechanism leading to malabsorption of dietary fats and
carbohydrates protecting from diet-induced weight gain.
Lymphatic Flow During Lipid Absorption
Spontaneous lacteal contraction, in concert with adjacent
smooth muscles, is also essential for drainage of dietary
lipids. Choe et al44 investigated lacteal drainage of dietary
lipids and other lipophilic molecules in vivo by using
intravital imaging and a lymphatic-green ﬂuorescent protein
reporter mouse. Lacteal contraction was shown to be
regulated by the autonomic nervous system, and to be
increased by acetylcholine and decreased by norepineph-
rine. Ganglion-blocking agents, such as mecamylamine and
pentolinium, which reduce smooth muscle motility in the
intestine,69 decrease lacteal contraction, supporting enteric
nervous system control of lacteal contraction and
drainage.44
Previous studies have suggested that drainage of the
lipid-rich lymph through gut lymphatics is driven by the
intrinsic pumping activity of the collecting vessels equipped
with smooth muscle cells and 1-way valves that prevent
backﬂow.70–72 However, a recent study showed that col-
lecting lymphatic vessels isolated from murine visceral
cavities display minimal contractile behavior73 suggesting
that their contribution during lipid absorption is not sig-
niﬁcant. Lymphatic pumping activity is regulated by intra-
luminal pressure74 and wall shear stress75 via differential
release of prostaglandins,76 NO,77,78 and histamine.79
Release of NO and histamine and contraction frequency of
intestinal collecting lymphatics were shown to increase
following olive oil administration in an early work with
rats.80 However, when lipid levels are very high they can
exert negative effects on lymphatic vessels as shown in a
recent study.81 This study where a 30% intralipid emulsion
was infused in the duodenum, showed that as the lipid
started rising (within 10–20 minutes) in the mesenteric
collecting duct, the vessel responded by reducing contrac-
tion frequency and amplitude and constricting the overall
vessel diameter, events that could be mediated by release of
prostaglandins.81 In vitro, treatment of LECs with very-low
density lipoproteins increased intracellular calcium accom-
panied by a signiﬁcant loss of diastolic relaxation suggesting
that, as in the blood vasculature, lipids can directly alter
shear-mediated events in the lymphatics.81 These ﬁndings
suggest that high lipids could negatively impact lymphatic
function and warrant further studies to understand the
mechanisms involved.
CD36
CD36/FAT (SR-B2), is a 75- to 88-kDa heavily glycosy-
lated transmembrane protein expressed in several tissues
and cell types including small intestine, muscle, the capillary
endothelium, adipocytes and macrophages.55,82,83 CD36
binds a range of ligands including long chain FA, native or
modiﬁed lipoproteins, pathogen-associated lipids and
thrombospondin-1.84 CD36 facilitates fatty acid transport
and plays a role in intestinal lipid absorption and transport
into the lymph. CD36 null (Cd36–/–) mice have impaired TG
and cholesterol secretion into the lymph after lipid infusion
via a duodenal ﬁstula despite producing smaller CMs.85,86 In
humans, single nucleotide polymorphisms in the CD36 gene
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that decrease CD36 protein level87,88 associate with defec-
tive CM production and clearance,89 but there is no infor-
mation on their potential inﬂuence on lymphatic transport
during lipid absorption.
Recent ﬁndings showed that conditional deletion of Cd36
in endothelial cells (using a Tie2 promoter), results in a
leaky epithelial barrier with neutrophil inﬁltration and
inﬂammation, and associates with abnormal extracellular
matrix remodeling in the proximal small intestine, as
observed in germline Cd36–/– mice.90 Systemically, endo-
toxemia is observed after an intragastric bolus of triolein
consistent with presence of a leaky gut. These results show
that endothelial CD36 is important for vascular homeostasis
and highlight potential role of the blood and lymphatic
endothelium in initiating gut inﬂammation.90
CD36 has established functions in cellular signaling91,92
related to lipid metabolism, angiogenesis, and inﬂamma-
tion.84 For example, CD36 binding thrombospondin-1 pro-
motes antiangiogenic signaling in microvascular endothelial
cell via interaction of CD36 with VEGFR-293 and decreases
VEGF-mediated AKT activation.94 CD36 is highly expressed
in LECs17 but molecular regulation of lymphatic signaling by
CD36 is unknown. Proliferation of LECs also relies on FAO
rather than glycolysis, and associates to higher expression of
FA transport proteins, including CD36.17 Unpublished data
from our laboratory show that CD36 enhances proteolytic
cleavage of pro–VEGF-C to the active form and that it reg-
ulates VEGF-C-mediated survival, function and signaling in
LECs (Cifarelli V et al, unpublished data).
Lymphatic Transport of Cholesterol and
Lipoproteins
The lymphatic vasculature regulates removal of choles-
terol from peripheral tissues95,96 and defective lymphatics
impair reverse cholesterol transport from atherosclerotic
plaques.97 The molecular mechanisms bridging lymphatic
biology to chronic inﬂammatory disease such as athero-
sclerosis are emerging,98 but little is known on the regula-
tion of cholesterol transport by gut lymphatics during
overfeeding and the metabolic syndrome. In the intestine,
key players in cholesterol transport and absorption across
the enterocyte brush border are Niemann-Pick C 1-like
protein 1, a cholesterol uptake transporter, and the adeno-
sine triphosphate–binding cassette (ABC) proteins ABCG5
and ABCG8, cholesterol efﬂux transporters.3 The FA trans-
locase CD36, expressed in epithelial cells lining the small
intestine, has also been implicated in cholesterol transport
on brush-border membranes.55,86 Once in the enterocyte,
cholesterol is either incorporated into CMs, or released via
ABCG8 to bind apolipoprotein A1 in high-density lipopro-
teins. Deletion of ABCG5 or ABCG8 reduces dietary TGs and
cholesterol in the lymph,99 but the regulation of dietary
cholesterol transport via gut lymphatics remains poorly
studied.
Role of VEGF-D in Lipoprotein Metabolism
Similar to VEGF-C, VEGF-D is a ligand of VEGFR-3, but it
does not appear to play a role in the regulation of lacteal CM
absorption. VEGF-D is produced by several tissues including
the small intestine.100 A recent study showed that VEGF-D
plays an important role in metabolism and uptake of CM
remnants (CR) by the liver.101 Vegfd deletion on a hyper-
lipidemic background (mice deﬁcient of low density
lipoprotein [ldl] receptor and expressing only apoB100;
ldlr–/–ApoB100–/–) markedly increased cholesterol and TG
accumulation in CMs and CR particles. Thus, VEGF-D regu-
lates hepatic CR clearance rather than intestinal absorption,
which is not affected in Vegfd knockout mice.
Conclusions and Perspective
Accumulating evidence clearly show that impaired
lacteal lymphangiogenesis or modulation of lacteal perme-
ability via cell-cell junctions protects against diet-induced
obesity and improves insulin sensitivity. However, the link
between gut lymphatics and the metabolic syndrome is not
completely understood and likely to involve multiple
mechanisms. For example, enteroendocrine cells of the
small intestine secrete 2 incretin hormones such as glucose-
dependent insulinotropic polypeptide and glucagon-like
peptide-1 to promote glucose-stimulated insulin secretion
in response to the absorption of fat and carbohydrate.
Changes in lacteal permeability and/or lymphangiogenesis
could redirect glucose-dependent insulinotropic poly-
peptide and glucagon-like peptide-1 toward the blood cir-
culation where they would be rapidly degraded. This would
likely contribute to affect adiposity and improve insulin
sensitivity observed in models of defective lacteals. The
lymph ﬁstula rat model is well suited for the study of
incretin secretion by the gastrointestinal tract58 and offers
new research opportunities to address these fundamental
questions. In addition, more research is required to eluci-
date roles and mechanisms of VEGFs and their respective
receptors in regulating lipid trafﬁcking and ﬂux in periph-
eral tissues such as the liver whose lymphatics are poorly
studied.102 Nrp1;Flt1 mutants had reduced liver TG content
and did not develop hepatic steatosis after 8 weeks of high-
fat-diet feeding compared with the control group.20 How-
ever, whether defective gut lymphatics leads to less
accumulation of lipid in the liver has not been comprehen-
sively studied and it is likely to be an important contributor
to the improved insulin sensitivity observed in models of
defective lacteals during diet-induced obesity.
The importance of gut lymphatics in lipid metabolism is
now emerging. Numerous studies have advanced our
understanding of the regulation of lipid uptake by gut
lymphatics, emphasizing that modulation of lacteal perme-
ability and proliferation could reverse diet-induced obesity
in rodent models. However, more research is needed to
address the speciﬁc link between gut lymphatics and sys-
temic metabolism. The development of experimental models
for studying intestinal lymphatics will be important in
examining its role and molecular mechanisms in physio-
logical and pathophysiological conditions.
Metabolic pathways impact lymphangiogenesis; glycolysis
provides energy for proliferating lymph vessels, while FAO
regulates lymphangiogenesis.103 However, the molecular
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pathways activated in gut lymphatics during lipid intake and
how they are altered with overfeeding are still unknown. A
better understanding of these pathways could help develop
new therapies for the treatment of obesity by reducing the
absorption of excess dietary lipids and regulating insulin
resistance.
A bidirectional crosstalk exists between the lymphatic
vasculature and adipose tissue.104 The effect of obesity and
associated complications such as hyperinsulinemia and
inﬂammation on gut lymphatic function is largely unex-
plored. Chronic inﬂammation, endotoxemia and changes in
the gut microbiota, key features of the metabolic syn-
drome105,106 are now emerging as factors that impair
integrity and permeability of gut lymphatics in rodent
models. For example, hyperglycemia-induced oxidative
stress causes degradation of newly synthesized VEGFR-3 in
the Golgi, reducing availability of VEGFR-3 at the cell surface
independent of VEGF-C stimulation. Deletion of epsin, an
adaptor protein that mediates clathrin-dependent endocy-
tosis, protects VEGFR-3 against degradation during diabetes
and ameliorates diabetes-triggered inhibition of lym-
phangiogenesis.107 Diabetes increases permeability of the
collecting lymphatics108 as well as pathogen-mediated
chronic inﬂammation in the gut.109 Integrity of the lacteals
has been shown to be essential for villus structure and
function. Ablation of intestinal lacteals causes disruption of
blood vessels and villi architecture, which leads to invasion
of intestinal pathogens into the circulatory system and can
cause septic shock and death.110 In summary, the lymphatic
system in the intestine represents an open area for future
investigation and additional research could advance our
understanding and beneﬁt the development of new thera-
peutic strategies.
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